Abbott Labs’ rapid COVID-19 tests begin to ship worldwide

Abbott Laboratories (NYSE: ABT) began shipping out its new COVID-19 rapid tests this week, as both the U.S. government and World Health Organization have ordered the low-cost test.

The White House Monday announced that 150 million of the $5 tests would be shipped in the coming weeks, many to nursing homes and assisted living communities and other populations vulnerable to spread of the coronavirus. The World Health Organization, through a partnership with the Bill & Melinda Gates Foundation, has also ordered 120 million tests from Abbott and South Korea-based SD Biosensor to be shipped to low-income countries over the next six months.

The Food and Drug Administration in late August approved emergency use authorization for the tests, which are the size of a credit card and take 15 minutes to produce results. Chicago-based Abbott has said the Westbrook production plant, which opened in July, will produce 50 million tests a month by October. The company’s Maine headquarters are in Scarborough. Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024